Pharma Wants More Clarity On Use Of Auxiliary Products In EU Trials
Executive Summary
Pharmaceutical companies say that more clarification is needed on a European Commission proposal that offers a revised definition for investigational medicinal products and deals with the use of auxiliary medicinal products in clinical trials.